Clinical trial
Pharmacokinetic Properties of Fondaparinux Sodium in Morbidly Obese Volunteers
NCT00436787 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetic Properties of Fondaparinux Sodium in Morbidly Obese Volunteers
- Lead sponsor
- University of Pittsburgh
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- December 31, 2007
- Enrollment
- 21 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.